These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1320606)

  • 1. Effect of pH on antibiotics used to treat anaerobic infection.
    Winstanley TG; Wilcox MH; Spencer RC
    J Antimicrob Chemother; 1992 May; 29(5):594-5. PubMed ID: 1320606
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1649-54. PubMed ID: 8215278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria.
    Venezia RA; Yocum DM; Robbiano EM; Echols RM
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1858-61. PubMed ID: 2178340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensitivity of clinical isolates of anaerobic species to piperacillin-tazobactam and other antimicrobial agents.
    Namavar F; Severin WP; Stobberingh E; Smeets T; MacLaren DM
    J Antimicrob Chemother; 1994 Sep; 34(3):415-9. PubMed ID: 7829416
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.
    Schaumann R; Funke M; Janssen E; Rodloff AC
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3413-6. PubMed ID: 22430962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
    Edmiston CE; Krepel CJ; Kehl KS; Seabrook GR; Somberg LB; Almassi GH; Smith TL; Loehrl TA; Brown KR; Lewis BD; Towne JB
    J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2471-6. PubMed ID: 7840591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.
    Falagas ME; McDermott L; Snydman DR
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2047-9. PubMed ID: 9303414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of anaerobic bacteria to the new streptogramin RP 59500 in vitro.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1064-7. PubMed ID: 2559846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
    Tan TY; Ng LS; Kwang LL; Rao S; Eng LC
    Anaerobe; 2017 Feb; 43():69-74. PubMed ID: 27890724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
    Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
    Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria.
    Nord CE
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S15-8. PubMed ID: 8953101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ceftriaxone combined with tazobactam against anaerobic bacteria.
    Wüst J; Hardegger U
    Eur J Clin Microbiol Infect Dis; 1994 Feb; 13(2):177-81. PubMed ID: 8013494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics.
    Dubreuil L; Devos J; Neut C; Romond C
    Antimicrob Agents Chemother; 1984 Jun; 25(6):764-6. PubMed ID: 6742819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative activity of 9 beta-lactamines, clindamycin and metronidazole on strictly anaerobic bacteria].
    Derriennic M; Reynaud A; Launay C; Courtieu AL
    Pathol Biol (Paris); 1987 May; 35(5):572-6. PubMed ID: 3302862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of anaerobic bacteria to FCE 22101.
    Nord CE; Lindmark A; Person I
    Antimicrob Agents Chemother; 1987 May; 31(5):831-3. PubMed ID: 3038012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of piperacillin/tazobactam in the treatment of experimental intra-abdominal infections.
    Nord CE; Lahnborg G
    Eur J Surg Suppl; 1994; (573):45-9. PubMed ID: 7524795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of the Etest method for antimicrobial susceptibility testing of obligate anaerobes].
    Rokosz A; Sawicka-Grzelak A; Kot K; Meszaros J; Łuczak M
    Med Dosw Mikrobiol; 2001; 53(2):167-75. PubMed ID: 11757426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactam.
    Jacobus NV; Immermann FW; Gupte JM; Testa RT
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S344-8. PubMed ID: 8391862
    [No Abstract]   [Full Text] [Related]  

  • 20. Anaerobic cocci and their resistance patterns to penicillin, cefoxitin, clindamycin and metronidazole: a Bulgarian study.
    Boyanova L; Osmanliev D; Petrov D; Mitov I; Usunova I; Petrov S; Minchev TZ
    Clin Microbiol Infect; 2000 Nov; 6(11):623-4. PubMed ID: 11168069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.